Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2285 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Sanofi-Aventis to acquire BiPar Sciences

Under the agreement, the purchase price will depend on the achievement of milestone payments related to the development of BSI-201 which could achieve a maximum of $500 million.

NeoStem raises $11m in financing

NeoStem, a provider of adult stem cell collection and banking services, has completed a private placement financing totaling $11m from three Asia-based investors, including a private equity firm

Cortex Q4 net loss decreases slightly

The reported losses included non-cash stock-based compensation charges for the quarters ended December 31, 2008 and 2007 of approximately $236,000 and $533,000, respectively. For the fiscal year ended